Guest Author: Pamela L. Popp MA JD DFASHRM CPHRM AIM DSA Executive Vice President/Chief Risk Officer Western Litigation In January of 2008, I joined the ranks of sepsis survivors. I too was placed on a ventilator, given months of antibiotic and antif…
Guest Author: Susan A. Irick, MS, RN, ACNP-C Disease Manager for Pneumonia and Sepsis Northeast Georgia Medical Center Sepsis is a term I have heard my entire nursing career. It never had quantifiable significance to me until the past 3 years. Now, sep…
Author: CDC Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) Wondering how antibiotic resistance in foodborne bacteria has changed over time? You’re in luck. With CDC’s new interactive tool, NARMS Now: Human Data, you can view trends in antibiotic resistance over the past two decades for four bacteria transmitted commonly through food: Campylobacter, E. coli
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,